Cardiovascular Diseases Clinical Trial
To longitudinally investigate multigenerational familial clustering of plasma low density lipoprotein cholesterol (LDL-C), with particular emphasis on the influences of apoE genotypes and various 'behaviors'.
BACKGROUND:
Elevated concentrations of plasma low density lipoprotein cholesterol (LDL-C), a major risk
factor for coronary heart disease, cluster significantly in families. This clustering has
been observed in cross-sectional studies in both black and white families, but longitudinal
data on the familial clustering of LDL-C are virtually nonexistent.
DESIGN NARRATIVE:
The longitudinal study will provide new and important information about changes in the
familial low density lipoprotein cholesterol (LDL-C) correlations in black and white
families from the period of shared household environments to that of separate households,
using families from the Princeton Lipid Research Clinics (LRC) Prevalence (1973-75) and
Family Studies (1975-76). The study will also provide important information on changes in
individual LDL-C levels over the same 25 year period. The former student participants were
six to 18 years of age and are now 32 to 45 years of age; their parents were (largely) 26 to
55 years of age and are now 51 to 80 years of age. Plasma LDL-C concentrations in children
and adults have been shown to associate with the apolipoprotein (apo) E genotype, with
obesity, and with such elective behaviors as diet, cigarette smoking, and physical activity.
In the LRC Study, measurements were made of LDL-C, body habitus, elective behaviors, and the
family history of cardiovascular disease (CVD). The study will obtain repeat measures of
these factors, plus determine the apo E isoforms. Changes in individual LDL-C levels and in
familial associations can then be assessed in association with apo E isoforms, body
composition, elective behaviors, and family history of CVD. Family members share ranges of
body weight, patterns of fat distribution, dietary and smoking habits, and physical activity
levels. The extent to which the familial clustering of LDL-C levels is determined by apo E
isoforms interacting with the similar levels of obesity, and with the similar behaviors, is
not currently known.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|